| Tissue/tumor type | Increased expression | Decreased expression |
| Breast [26, 27] | miR-21, miR-29b-2 | miR-125b, miR-145 miR-10b, miR-155, miR-17-5p, miR-27b | Ovarian [28, 29] | miR-141, miR-200(a-c), miR-221 | let-7f, miR-140, miR-145, miR199a, miR-424 | Endometrial [30ā32] | miR-103, miR-107, miR-185, miR-205, miR-210, miR-449 | miR-99b, miR-152, miR-193, miR-204, miR-221, let-7i | Glioblastoma [4, 25] | miR-221, miR-21 | miR-181a, miR-181b, miR-181c | Chronic lymphocytic leukaemia [24] | | miR-15, miR-16 | Lymphoma [4, 11] | miR-155, miR-17-92cluster | miR-15a | Colorectal [4, 11, 25] | miR-10a, miR-17-92 cluster, miR-20a, miR-24-1, miR-29b-2, miR-31 | miR-143, miR-145, let-7 | Thyroid [4, 25] | miR-221, miR-222, miR-146, miR-181b, miR-197, miR-346 | | Hepatocellular [4, 25] | miR-18, miR-224 | miR-199a, miR-195, miR-200a, miR-125a | Testicular [11] | miR-372, miR-373 | | Pancreatic [4, 11, 25] | miR-221, miR-376a, miR301, miR-21, miR-24-2, miR-100, miR-103-1,2, miR-107, miR-125b-1 | miR-375 | Cholangiocarcinoma [25] | miR-21, miR-141, miR-200b | | Prostate [11] | let-7d, miR-195, miR-203 | miR-128a | Gastric [4, 11, 25] | miR-223, miR-21, miR-103-2 | miR-218-2 | Lung [4, 11, 25] | mir-17-92 cluster, miR-17-5p | let-7 family |
|
|